EMEA-000020-PIP01-07-M05

Key facts

Invented name
Celsentri
Active substance
maraviroc
Therapeutic area
Infectious diseases
Decision number
P/0237/2015
PIP number
EMEA-000020-PIP01-07-M05
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
ViiV Healthcare UK Ltd

United Kingdom
Tel. +44 (0)20 8380 6215
E-mail: neil.p.shortman@viivhealthcare.com

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000020-PIP01-07-M05
Compliance opinion date
29/04/2016
Compliance outcome
positive

Decision

How useful was this page?

Add your rating